Keros Therapeutics (KROS) EBT Growth (1y) (2020 - 2025)
Keros Therapeutics (KROS) EBT Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - | 45.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.38% |
| Sep 30, 2025 | 83.56% |
| Jun 30, 2025 | 27.26% |
| Mar 31, 2025 | 467.62% |
| Dec 31, 2024 | -0.33% |
| Sep 30, 2024 | 31.12% |
| Jun 30, 2024 | 50.50% |
| Mar 31, 2024 | -9.51% |
| Dec 31, 2023 | -53.36% |
| Sep 30, 2023 | -227.02% |
| Jun 30, 2023 | -235.35% |
| Mar 31, 2023 | -62.78% |
| Dec 31, 2022 | -501.46% |
| Sep 30, 2022 | -15.61% |
| Jun 30, 2022 | -74.54% |
| Mar 31, 2022 | -52.74% |
| Dec 31, 2021 | 53.72% |
| Sep 30, 2021 | -68.95% |
| Jun 30, 2021 | -45.23% |
| Mar 31, 2021 | -31.26% |